A multi-center, randomized, clinical trial comparing adhesive polyurethane foam dressing and adhesive hydrocolloid dressing in patients with grade II pressure ulcers in primary care and nursing homes

Abstract

BackgroundPressure ulcers (PrUs) are ischemic wounds in the skin and underlying tissues caused by long-standing pressure force over an external bone or cartilaginous surface. PrUs are an important challenge for the overall health system because can prolong patient hospitalization and reduce quality of life. Moreover, 95% of PrUs are avoidable, suggesting they are caused by poor quality care assistance. PrUs are also costly, increasing national costs. For example, they represent about 5% of overall annual health expenses in Spain. Stages I and II PrUs have a combined prevalence of 65%. According main clinical guidelines, stage II PrUs (PrU-IIs) are usually treated by applying special dressings (polyurethane or hydrocolloid). However, little scientific evidence regarding their efficacy has been identified in scientific literature. Our aim is to assess the comparative efficacy of adhesive polyurethane foam and hydrocolloid dressings in the treatment of PrU-IIs in terms of healed ulcer after 8 weeks of follow-up.Methods/designThis paper describes the development and evaluation protocol of a randomized clinical trial of two parallel treatment arms. A total of 820 patients with at least 1 PrU-II will be recruited from primary health care and home care centers. All patients will receive standardized healing procedures and preventive measures (e.g. positional changes and pressure-relieving support surfaces), following standardized procedures. The main outcome will be the percentage of wounds healed after 8 weeks. Secondary outcomes will include cost-effectiveness, as evaluated by cost per healed ulcer and cost per treated patient and safety evaluated by adverse events.DiscussionThis trial will address the hypothesis that hydrocolloid dressings will heal at least 10% more stage II PrUs and be more cost-effective than polyurethane foam dressings after 8 weeks.Trial registrationThis trial has been registered with controlled-trials number ISCRCTN57842461 and EudraCT 2012-003945-14.

Encapsulation of Satureja khuzistanica extract in alginate hydrogel accelerate wound healing in adult male rats

“…Hence, it can play an important role in wound healing [27]. Alginate is another biomaterial that improves wound healing via moisture supply and absorption of wound exudate [28]. Thus, according to the properties of these biomaterials, the combination of them together with medicinal plants is a suitable solution for wound healing.…”

The efficacy of sacral foam dressing in preventing sacral pressure injury: A systematic review and meta‐analysis

“…Their ease of application and removal, coupled with their ability to act as a protective barrier against contamination, makes them an ideal prophylactic tool against pressure injuries 28 . However, on the contrary, they may not be suitable for wounds with heavy exudate, can be costlier than other preventive measures and may cause skin maceration if not changed regularly 30,31 . Additionally, individual patient reactions to the dressing material may vary 32 …”

Plasma‐Activated Substrate with a Tropoelastin Anchor for the Maintenance and Delivery of Multipotent Adult Progenitor Cells

“…PU, as the base material for the wound patch, is commercially available as a medical‐grade polymer and is widely used in wound dressing applications . PU‐based foam, nanofiber, and film dressings are conformable, durable, and have been shown to maintain moisture, promote wound exudate drainage, and lead to better wound healing …”